A multidisciplinary panel discusses recent updates and advances in molecular testing and treatment for stage I-IIIA non-small cell lung cancer (NSCLC).
EP. 1: Recommendations for Molecular Testing in Non-Small Cell Lung Cancer (NSCLC)
October 5th 2022A panel of lung cancer experts provides an overview of molecular testing in early-stage non-small cell lung cancer (NSCLC) and recommendations for biomarkers to test for and at what treatment stages to perform testing.